Immunological status of the stomach in inflammatory bowel disease - Comparison between ulcerative colitis and Crohn's disease

Digestion

Volumn 77, Issue 3-4, 2008, Pages 145-149

  Ando, Takafumi ^a   Watanabe, Osamu ^a   Nobata, Kazuo ^a   Ishiguro, Kazuhiro ^a   Maeda, Osamu ^a   Ishikawa, Daisuke ^a   Hasegawa, Motofusa ^a   Kondo, Shinya ^a   Kato, Tsuyoshi ^a   Ohmiya, Naoki ^a   Niwa, Yasumasa ^a   Goto, Hidemi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic inflammatory process; Crohn's disease; Functional dyspepsia; Inflammatory bowel disease; Stomach, immunological status; Ulcerative colitis

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8;

ADULT; ARTICLE; BIOPSY; CELL INFILTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DYSPEPSIA; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; HUMAN TISSUE; IMMUNOLOGY; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NEUTROPHIL CHEMOTAXIS; ORGAN CULTURE; PRIORITY JOURNAL; STOMACH ANTRUM; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; COLITIS, ULCERATIVE; CROHN DISEASE; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTRIC MUCOSA; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; NEUTROPHIL INFILTRATION; ORGAN CULTURE TECHNIQUES; STOMACH;

EID: 50149100369     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000140973     Document Type: Article

References (32)

1. Fiocchi C: Inflammatory bowel disease: current concepts of pathogenesis and implications for therapy. Minerva Gastroenterol Dietol 2002;48:215-226.
2. Casellas F, Vivancos JL, Sampedro M: Relevance of the phenotypic characteristics of Crohn's disease in patient perception of health-related quality of life. Am J Gastroenterol 2005;100:2737-2742.
3. Knapp AB, Mirsky FJ, Dillon EH, Korelitz BI: Successful infliximab therapy for a duodenal stricture caused by Crohn's disease. Inflamm Bowel Dis 2005;11:1123-1125.
4. Lemberg DA, Clarkson CM, Bohane TD, Day AS: Role of esophagogastroduodenoscopy in the initial assessment of children with inflammatory bowel disease. J Gastroenterol Hepatol 2005;20:1696-1700.
5. Moriyama T, Matsumoto T, Jo Y, Yada S, Hirahashi M, Yao T, Iida M: Mucosal proinflammatory cytokine and chemokine expression of gastroduodenal lesions in Crohn's disease. Aliment Pharmacol Ther 2005;21:85-91.
6. Remes-Troche JM, Martinez-Benitez B, Valdovinos-Diaz MA: Crohn's disease of the esophagus. Gastroenterology 2006;130:1029, 1376.
7. Haggitt RC, Meissner WA: Crohn's disease of the upper gastrointestinal tract. Am J Clin Pathol 1973;59:613-622.
8. Schmitz-Moormann P, Malchow H, Pittner PM: Endoscopic and bioptic study of the upper gastrointestinal tract in Crohn's disease patients. Pathol Res Pract 1985;179:377-387.
9. Korelitz BI, Waye JD, Kreuning J, Sommers SC, Fein HD, Beeber J, Gelberg BJ: Crohn's disease in endoscopic biopsies of the gastric antrum and duodenum. Am J Gastroenterol 1981;76:103-109.
10. Kaufman SS, Vanderhoof JA, Young R, Perry D, Raynor SC, Mack DR: Gastroenteric inflammation in children with ulcerative colitis. Am J Gastroenterol 1997;92:1209-1212.
11. Ruuska T, Vaajalahti P, Arajarvi P, Maki M: Prospective evaluation of upper gastrointestinal mucosal lesions in children with ulcerative colitis and Crohn's disease. J Pediatr Gastroenterol Nutr 1994;19:181-186.
12. Tobin JM, Sinha B, Ramani P, Saleh AR, Murphy MS: Upper gastrointestinal mucosal disease in pediatric Crohn disease and ulcerative colitis: a blinded, controlled study. J Pediatr Gastroenterol Nutr 2001;32:443-448.
13. Berrebi D, Languepin J, Ferkdadji L, Foussat A, De Lagausie P, Paris R, Emilie D, Mougenot JF, Cezard JP, Navarro J, Peuchmaur M: Cytokines, chemokine receptors, and homing molecule distribution in the rectum and stomach of pediatric patients with ulcerative colitis. J Pediatr Gastroenterol Nutr 2003;37:300-308.
14. Hart AL, Al-Hassi HO, Rigby RJ, Bell SJ, Emmanuel AV, Knight SC, Kamm MA, Stagg AJ: Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology 2005;129:50-65.
15. Giampaolo B, Giuseppe P, Michele B, Alessandro M, Fabrizio S, Alfonso C: Treatment of active steroid-refractory inflammatory bowel diseases with granulocytapheresis: our experience with a prospective study. World J Gastroenterol 2006;14:2201-2204.
16. Sartor RB: Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 1994;106:533-539.
17. Fiocchi C: Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182-205.
18. Kishimoto T: The biology of interleukin-6. Blood 1989;74:1-10.
19. Ando T, Kusugami K, Ohsuga M, Shinoda M, Sakakibara M, Saito H, Fukatsu A, Ichiyama S, Ohta M: Interleukin-8 activity correlates with histological severity in Helicobacter pylori -associated antral gastritis. Am J Gastroenterol 1996;91:1150-1156.
20. Ando T, Kusugami K, Ohsuga M, Ina K, Shinoda M, Konagaya T, Sakai T, Imada A, Kasuga N, Nada T, Ichiyama S, Blaser MJ: Differential normalization of mucosal interleukin-8 and interleukin-6 activity after Helicobacter pylori eradication. Infect Immun 1998;66:42-47.
21. Crabtree JE: Role of cytokines in pathogenesis of Helicobacter pylori -induced mucosal damage. Dig Dis Sci 1998;43:46-55.
22. Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;1:1311-1314.
23. Marshall BJ, Goodwin CS, Warren JR, Murray R, Blincow ED, Blackbourn SJ, Phillips M, Waters TE, Sanderson CR: Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988;2:1437-1442.
24. Blaser MJ: Hypotheses on the pathogenesis and natural history of Helicobacter pylori - induced inflammation. Gastroenterology 1992;102:720-727.
25. Walsh JH, Peterson WL: The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engl J Med 1995;333:984-991.
26. Suzuki T, Ina K, Nishiwaki T, Tsuzuki T, Okada T, Furuta R, Nobata K, Ando T, Kusugami K, Goto H: Differential roles of interleukin-1β and interleukin-8 in neutrophil transendothelial migration in patients with Helicobacter pylori infection. Scand J Gastroenterol 2004;39:313-321.
27. Mizuno T, Ando T, Nobata K, Tsuzuki T, Maeda O, Watanabe O, Minami M, Ina K, Kusugami K, Peek RM, Goto H: Interleukin-17 levels in Helicobacter pylori -infected gastric mucosa and pathologic sequelae of colonization. World J Gastroenterol 2005;11:6305-6311.
28. El-Omar E, Penman I, Cruikshank G, Dover S, Banerjee S, Williams C, McColl KE: Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulphasalazine. Gut 1994;35:1385-1388.
29. Halme L, Rautelin H, Leidenius M, Kosunen TU: Inverse correlation between Helicobacter pylori infection and inflammatory bowel disease. J Clin Pathol 1996;49:65-67.
30. Wagtmans MJ, Witte AM, Taylor DR, Biemond I, Veenendaal RA, Verspaget HW, Lamers CB, van Hogezand RA: Low seroprevalence of Helicobacter pylori antibodies in historical sera of patients with Crohn's disease. Scand J Gastroenterol 1997;32:712-718.
31. Piodi LP, Bardella M, Rocchia C, Cesana BM, Baldassarri A, Quatrini M: Possible protective effect of 5-aminosalicylic acid on Helicobacter pylori infection in patients with inflammatory bowel disease. J Clin Gastroenterol 2003;36:22-25.
32. Kusugami K, Fukatsu A, Tanimoto M, Shinoda M, Haruta J, Kuroiwa A, Ina K, Kanayama K, Ando T, Matsuura T, Yamaguchi T, Morise K, Ieda M, Iokawa H, Ishihara A, Sarai S: Elevation of interleukin-6 in inflammatory bowel disease is macrophage- and epithelial cell-dependent. Dig Dis Sci 1995;40:949-959.